- ChineseInvestors.com has become top financial-information website
- The company is also advancing its cannabidiol program
- CIIX offers investors multiple revenue streams, healthy return potential
Based in San Gabriel, California, ChineseInvestors.com Inc. (OTCQB: CIIX) offers a proprietary financial-news media and content platform. The company has become a foremost financial-information website for Chinese-speaking investors in the United States and China. Via its main website – www.ChineseInvestors.com – CIIX offers an array of investor-education products and services. CIIX is also laying the foundation to capitalize on increasing demand for CBD (cannabidiol)-based nutrition and health products.
CIIX’s investor-education products and services include real-time market commentary, analysis and educational-related services in Chinese-language character sets. The company also provides consultative services to smaller private companies considering becoming public, as well as advertising and public-relations-related support services.
As a core element of its services, CIIX features its exclusive ChineseInvestors Method, an innovative integration of a disciplined investing process, web-based tools, personalized instructions and invaluable support. With this strategy, the company provides reliable market information to assist investors in making informed investment decisions and meeting their individual financial goals.
CIIX raises investor awareness through investor conferences and road shows. The company has a subscriber base of free and paying members, with its base membership – 95% – primarily located in the United States and Canada. CIIX services are largely delivered to U.S. public and private companies and U.S. residents and citizens. The company delivers its services in both traditional and simplified Chinese-language character sets (http://cnw.fm/w5kUm).
CIIX’s CBD initiatives are carried out by its subsidiary, CBD Biotech Inc. In essence, CIIX is taking advantage of its own financial expertise to establish itself as a leader in China’s developing CBD industry. Through CBD Biotech, CIIX has established a three-year development plan to capitalize on the union of CBD and the nutrition and health products market in mainland China.
Subsequent to entering into a wholesale agreement with a well-known CBD health brand in December 2016, CIIX formally launched the website ChineseCBDOil.com (http://cnw.fm/TpvQ6). This website is one of the world’s first online stores in the Chinese language, providing industrial-hemp-derived CBD products for Chinese-speaking customers around the world. Products available on the site include soft gels, capsules and concentrates. In addition, CIIX opened a retail store in San Gabriel, California, which has a high Chinese population.
Of note to investors is that CIIX CEO Warren Wang has said the company is planning an IPO of wholly owned CBD Biotech. In the announcement, Wang noted that CIIX hopes for a Nasdaq IPO of CBD Biotech early in 2020. CIIX would then concentrate on identifying an acquisition target for further growth (http://cnw.fm/zL81r).
CIIX continues to focus on providing premier financial information via its main website. At the same time, the company is leveraging the opportunity for significant revenue streams through its CBD Biotech subsidiary. For investors, CIIX offers a two-pronged business strategy for a healthy return on investment.
For more information, visit the company’s website at www.ChineseInvestors.com
NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.
